Procalcitonin: a marker of infection not subverted by treatment with interleukin-6 receptor inhibition

Pediatr Infect Dis J. 2013 Sep;32(9):1040. doi: 10.1097/INF.0b013e318295a3d0.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Bacterial Infections / diagnosis*
  • Bacterial Infections / pathology*
  • Biomarkers / blood*
  • Calcitonin / blood*
  • Calcitonin Gene-Related Peptide
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Protein Precursors / blood*
  • Receptors, Interleukin-6 / antagonists & inhibitors*
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • CALCA protein, human
  • Immunosuppressive Agents
  • Protein Precursors
  • Receptors, Interleukin-6
  • Calcitonin
  • tocilizumab
  • Calcitonin Gene-Related Peptide